MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12883-020-01805-1

Медицинская библиотека · BMC neurology · 2020

Prediction of generalization of ocular myasthenia gravis under immunosuppressive therapy in Northwest China.

Ding Jiaqi, Zhao Sijia, Ren Kaixi, Dang Dan, Li Hongzeng, Wu Fang, Zhang Min, Li Zhuyi, Guo Jun

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

It is well demonstrated that immunosuppressants can reduce, but not eliminate the risk of generalized development in ocular myasthenia gravis (OMG). In this study, we aimed to explore the predictive factors of generalized conversion of OMG patients who received immunosuppressive treatments.

METHODS

OMG patients under immunosuppressive treatments in Tangdu Hospital from June 2008 to June 2012 were retrospectively reviewed. Baseline clinical characteristics were documented. Patients were followed up regularly by face-to-face interview and the main outcome measure was generalized conversion. The logistic regression analysis was performed to determine the predictive factors of generalization of OMG.

RESULTS

Two hundred twenty-three eligible OMG patients completed the final follow-up visit and 38 (17.0%) progressed to generalized MG (GMG) at a median time to generalization of 0.9 year. Patients with adult onset and positive repetitive nerve stimulation (RNS) of facial or axillary nerve had higher conversion rate than those with juvenile onset and negative RNS (p = 0.001; p = 0.019; p = 0.015, respectively). Adult-onset patients converted earlier than juvenile-onset OMG patients (p = 0.014). Upon multivariate logistic regression analysis, age of onset (Odds ratio [OR] 1.023, 95% confidence interval [CI] 1.006-1.041, p = 0.007) and positive facial nerve RNS (OR 2.826, 95%CI 1.045-5.460, p = 0.038) were found to be positively associated with generalized development. Moreover, an obviously negative association was found for disease duration (OR 0.603, 95%CI 0.365-0.850, p = 0.019).

CONCLUSIONS

Age of onset, disease duration and facial nerve RNS test can predict generalized conversion of OMG under immunosuppressive therapy. Adult-onset, shorter disease duration and facial nerve RNS-positive OMG patients have a higher risk of generalized development.

Для цитирования: Ding Jiaqi, Zhao Sijia, Ren Kaixi, Dang Dan, Li Hongzeng, Wu Fang, Zhang Min, Li Zhuyi, Guo Jun. Prediction of generalization of ocular myasthenia gravis under immunosuppressive therapy in Northwest China.. BMC neurology. 2020. DOI: 10.1186/s12883-020-01805-1.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.